|
|
||||||||
J Thorac Cardiovasc Surg 2002;124:1225-1229
© 2002 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease (ACD) |
From the Departments of Cardiovascular Anesthesiology and Biostatistics/Epidemiology, Texas Heart Institute at St Luke's Episcopal Hospital, Houston, Tex.
Received for publication Aug 30, 2001. Revisions requested Jan 14, 2002; revisions received March 13, 2002. Accepted for publication March 13, 2002. Address for reprints: Nancy A. Nussmeier, MD, Director of Cardiovascular Anesthesia Research, Department of Cardiovascular Anesthesiology, Texas Heart Institute, 6720 Bertner Ave, Room O-520 (MC 1-226), Houston, TX 77225-0345 (E-mail: nnussmeier{at}heart.thi.tmc.edu).
Objectives: The effect of hormone replacement therapy on cardiovascular events in postmenopausal women is controversial. We investigated the roles of sex and hormone replacement status in female patients undergoing coronary artery bypass grafting.
Methods: We reviewed the records of 4259 consecutive patients aged 55 years or older who underwent primary elective isolated coronary artery bypass at our hospital between May 1996 and September 2001.
Results: Female sex with hormone replacement therapy was an independent predictor of decreased mortality, regardless of age. Mortality was 6.7% (61/905) for women not receiving hormone replacement therapy, 2.3% (6/256) for hormone replacement therapy recipients, and 2.7% (82/3098) for men (P < .01 for all comparisons). Of the characteristics examined, multivariate analysis indicated that independent predictors of mortality were advanced age, previous congestive heart failure, class IV angina, and female sex without hormone replacement (P < .005). Independent predictors of survival included use of an internal thoracic artery graft and white ethnicity. There were no significant intergroup differences in the incidence of nonfatal, morbid postoperative events.
Conclusions: Postmenopausal women undergoing coronary artery bypass had a significantly improved in-hospital survival if they had been receiving hormone replacement therapy. The improved survival might be related to one or more of the numerous cardiovascular effects of estrogen that are considered beneficial. A prospective randomized trial is needed to validate the observation that hormone replacement therapy is protective in this setting.
This article has been cited by other articles:
![]() |
J. D. Puskas, P. D. Kilgo, O. M. Lattouf, V. H. Thourani, W. A. Cooper, T. A. Vassiliades, E. P. Chen, J. D. Vega, and R. A. Guyton Off-pump coronary bypass provides reduced mortality and morbidity and equivalent 10-year survival. Ann. Thorac. Surg., October 1, 2008; 86(4): 1139 - 1146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Puskas, F. H. Edwards, P. A. Pappas, S. O'Brien, E. D. Peterson, P. Kilgo, and T. B. Ferguson Jr Off-Pump Techniques Benefit Men and Women and Narrow the Disparity in Mortality After Coronary Bypass Grafting Ann. Thorac. Surg., November 1, 2007; 84(5): 1447 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Puskas, P. D. Kilgo, M. Kutner, S. V. Pusca, O. Lattouf, and R. A. Guyton Off-Pump Techniques Disproportionately Benefit Women and Narrow the Gender Disparity in Outcomes After Coronary Artery Bypass Surgery Circulation, September 11, 2007; 116(11_suppl): I-192 - I-199. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Edwards, V. A. Ferraris, D. M. Shahian, E. Peterson, A. P. Furnary, C. K. Haan, and C. R. Bridges Gender-Specific Practice Guidelines for Coronary Artery Bypass Surgery: Perioperative Management Ann. Thorac. Surg., June 1, 2005; 79(6): 2189 - 2194. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |